Sg Americas Securities, LLC Akero Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 14,507 shares of AKRO stock, worth $474,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,507

Previous 14,517 0.07%

Holding current value

$474,814

Previous $341,000 21.99%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$21.45 - $29.34 $214 - $293	-10 Reduced 0.07%	14,507 $416,000
Q2 2024 Jul 12, 2024	BUY	$18.31 - $24.62 $174,530 - $234,677	9,532 Added 191.21%	14,517 $341,000
Q1 2024 May 06, 2024	SELL	$17.76 - $31.18 $44,453 - $78,043	-2,503 Reduced 33.43%	4,985 $126,000
Q4 2023 Jan 12, 2024	SELL	$11.38 - $50.33 $132,531 - $586,143	-11,646 Reduced 60.87%	7,488 $175,000
Q3 2023 Oct 13, 2023	BUY	$41.19 - $52.25 $459,186 - $582,483	11,148 Added 139.59%	19,134 $968,000
Q2 2023 Jul 10, 2023	BUY	$36.89 - $56.88 $55,261 - $85,206	1,498 Added 23.09%	7,986 $373,000
Q1 2023 Apr 28, 2023	BUY	$37.27 - $50.24 $23,740 - $32,002	637 Added 10.89%	6,488 $248,000
Q4 2022 Feb 02, 2023	SELL	$33.44 - $54.8 $342,760 - $561,700	-10,250 Reduced 63.66%	5,851 $321,000
Q3 2022 Oct 31, 2022	SELL	$10.15 - $34.05 $53,937 - $180,941	-5,314 Reduced 24.81%	16,101 $548,000
Q2 2022 Jul 29, 2022	BUY	$8.0 - $15.01 $171,320 - $321,439	21,415 New	21,415 $202,000
Q4 2021 Feb 07, 2022	SELL	$19.87 - $26.24 $1.04 Million - $1.37 Million	-52,255 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$18.65 - $25.46 $536,038 - $731,771	28,742 Added 122.24%	52,255 $1.17 Million
Q2 2021 Aug 12, 2021	SELL	$24.81 - $32.35 $11,189 - $14,589	-451 Reduced 1.88%	23,513 $583,000
Q1 2021 May 13, 2021	BUY	$24.04 - $34.19 $576,094 - $819,329	23,964 New	23,964 $695,000
Q3 2020 Nov 09, 2020	SELL	$30.79 - $39.92 $187,418 - $242,993	-6,087 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$19.25 - $26.76 $117,174 - $162,888	6,087 New	6,087 $152,000
Q3 2019 Nov 04, 2019	SELL	$16.89 - $29.88 $168,900 - $298,800	-10,000 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$18.08 - $19.83 $180,799 - $198,299	10,000 New	10,000 $192,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Akero Therapeutics, Inc. Transaction History